Skip to main content
A

ASKA Pharmaceutical Holdings CO., Ltd. — Investor Relations & Filings

Ticker · 4886 ISIN · JP3119660003 T Manufacturing
Open in API
Filings indexed 37 across all filing types
Latest filing 2025-11-07 Regulatory Filings
Country JP Japan
Listing T 4886

About ASKA Pharmaceutical Holdings CO., Ltd.

https://www.aska-pharma.co.jp/english/

ASKA Pharmaceutical Holdings Co., Ltd. is a healthcare group engaged in the research, development, manufacturing, and sale of pharmaceuticals. The company specializes in hormone-related medicines, with a primary focus on three therapeutic areas: internal medicine, obstetrics and gynecology, and urology. It is a leading provider of treatments for thyroid disease. The product portfolio includes various hormone preparations, such as the emergency contraceptive pill NORLEVO® and leuprorelin acetate for injection, used in treating conditions like prostate cancer and endometriosis. The group actively pursues the creation of innovative products, including new antibody drugs, through research and development collaborations to meet evolving medical needs.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations regarding a report (in this case, the semi-annual report) rather than the report itself should be classified as Regulatory Filings (RNS). H1 2025
2025-11-07 Japanese
半期報告書－第5期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by ASKA Pharmaceutical Holdings Co., Ltd. under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet and income statement for the interim period ending September 30, 2025. As it is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial data, it is classified as an Interim/Quarterly Report. H1 2025
2025-11-07 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau Director. Section 1 explicitly states the reason for filing: reporting the resolutions passed at the Annual General Meeting (定時株主総会) held on June 24, 2025, based on the Financial Instruments and Exchange Act. Section 2 details the resolutions, which include dividend approval, election of directors and auditors, and shareholder proposals regarding share buybacks and articles of incorporation changes. The core content is the official results of shareholder voting (賛成, 反対, 棄権) from the AGM. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting.
2025-06-27 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-2. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2025
2025-06-20 Japanese
内部統制報告書－第4期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly cites the legal basis as "金融商品取引法第24条の４の４第１項" (Financial Instruments and Exchange Act Article 24-4-4, Paragraph 1). This specific filing requirement in Japan mandates the submission of an Internal Control Report, which is a comprehensive annual assessment of internal controls over financial reporting. This aligns perfectly with the scope of an Annual Report or a dedicated internal control disclosure, but given the specific title and legal citation, it is a formal regulatory filing detailing internal control effectiveness, which is often a component or standalone report accompanying the main annual filing (10-K equivalent in the US context, but here it's a specific Japanese disclosure). Since the definitions provided do not have a specific code for the Japanese 'Internal Control Report' (J-SOX), the closest fit that represents a comprehensive, formal annual assessment of financial reporting integrity, distinct from a simple earnings release or audit opinion, is the Annual Report (10-K) category, as this report is intrinsically linked to the annual financial statements. However, looking closely at the provided definitions, there is no direct match for a standalone 'Internal Control Report'. The document is a full report, not an announcement of a report (ruling 2). Given the comprehensive nature and regulatory requirement, it is a core financial disclosure. If we must choose from the list, and recognizing that this is a formal, comprehensive annual disclosure related to financial integrity, it is most closely related to the comprehensive annual reporting structure. Since '10-K' is defined as the 'Official yearly report covering company activity and full financial performance,' and this document details the internal controls underpinning that performance, it is the most appropriate classification among the choices, even if it is a specific Japanese regulatory document type. If 'RNS' (Regulatory Filings) were used as a fallback, it would be too generic. I will classify it as 10-K based on its function as a comprehensive annual control assessment.
2025-06-20 Japanese
有価証券報告書－第4期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is identified as a Japanese 'Yuka Shoken Hokokusho' (有価証券報告書), which is the Japanese equivalent of an Annual Report (10-K). The document header explicitly states '有価証券報告書' (Securities Report), cites the Financial Instruments and Exchange Act Article 24, Paragraph 1, and covers a full fiscal year (2024-04-01 to 2025-03-31). It contains comprehensive financial data and corporate disclosures, fitting the definition of an Annual Report. FY 2025
2025-06-20 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.